A Closer Look at RA Treatment: JAK Inhibitor Efficacy and Safety
In this episode, Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman interpret the latest safety and efficacy data for JAK inhibitors in RA, including the ORAL, BEACON, BEAM, SELECT, and FINCH series in bDMARD-IR MTX-IR MTX naive Also included is an in-depth discussion of JAK safety, including MACE and VTE, and use in the clinic including JAK cycling Presenters: Stanley B. Cohen, MDClinical ProfessorDepartment of Internal MedicineUniversity of Texas Southwestern Medical SchoolCo-DirectorDivision of RheumatologyPresbyterian HospitalCo-Medical DirectorMetroplex Clinical Research CenterDallas, Texas Sheetal Desai, MD, MSEdChief of RheumatologyProgram DirectorUniversity of California, IrvineIrvine, California Eric M. Ruderman, MDProfessor, Associate ChiefDivision of RheumatologyNorthwestern University Feinberg School of MedicineClinical Practice DirectorNorthwestern Medical GroupChicago, Illinois Download the accompanying slides at:https://bit.ly/37bm6cJ See the interactive video at:https://bit.ly/3oCOtpV